BIS

Fund Description
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index.
Fund Profile
Fund Name ProShares UltraShort Nasdaq Biotechnology
Fund Exchange Ticker BIS
Fund Sponsor ProShares
Fund ISIN US74347G8380
Net Expense Ratio 0.95 %
Fund Inception Date 7 April 2010
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Leveraged / Inverse
Asset Class Equities (Stocks)
Index Linked Passive
Index Name NASDAQ Biotechnology Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Inverse (-2x)
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 23 November 2022
Asset Under Management 5.78 Million (USD)
1 Month Total Return -10.40 %
Year To Date Return -2.59 %
1 Year Total Return -6.19 %
3 Year Annualized Total Return -29.46 %
NAV 19.5164
Share Outstanding 296,100
Top 10 Holdings (25 November 2022)
Constituent Name Constituent Ticker Constituent Type Weighting
Derivatives offset OTHR 1.9998360238
Net Other Assets (Liabilities) OTHR 0.9999998266
NASDAQ Biotechnology Index SWAP Citibank NA SWAP -0.5316206219
NASDAQ Biotechnology Index SWAP Bank of America NA SWAP -0.4970137393
NASDAQ Bio Index SWAP BNP SWAP -0.3423872427
NASDAQ Biotechnology Index SWAP Societe Generale SWAP -0.3026261435
NASDAQ Biotechnology Index SWAP UBS AG SWAP -0.2024870790
NASDAQ Biotechnology Index SWAP Morgan Stanley & Co. International PLC SWAP -0.1237011973